Veritas, Khaitan lead on Recipharm’s acquisition of stake in Nitin Lifesciences for 671 croreOctober 21 2015
Swedish firm Recipharm has picked up 74 per cent stake in sterile injectables maker Nitin Lifesciences for Rs. 671 crore ($103 million) in an all cash deal.
Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates Natasha Sethna and Tejasvi Saxena.
Khaitan & Co advised the promoters of Nitin Lifesciences with a team led by Partner Kalpana Unadkat along with Senior Associate Shweta Dwivedi and Associate Bidya Mohanty.
Khaitan Partner . . .
You need to have an active subscription to view this content.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports